BRKB-201

N/A

Report date: 2023/03/17 13:50:00

Base Information

Drug NameBRKB-201

Drug Alias NameBRKB-201

ClassificationBiologics > Protein drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBrickBio Inc

China Registration ClassN/A

Develop Information

Active CompaniesBrickBio Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A